Lecanemab approval in EU: what should we be ready for?- the EANM perspective

被引：1

作者：

Yakushev, Igor ^{[1
]}

Verger, Antoine ^{[2
]}

Brendel, Matthias ^{[3
]}

Cecchin, Diego ^{[4
]}

Fernandez, Pablo Aguiar ^{[5
,6
]}

Fraioli, Francesco ^{[7
]}

Grimmer, Timo ^{[8
]}

Tolboom, Nelleke ^{[9
]}

Traub-Weidinger, Tatjana ^{[10
]}

Guedj, Eric ^{[11
]}

Van Weehaeghe, Donatienne ^{[12
]}

机构：

[1] Tech Univ Munich, Sch Med, Klinikum Rechts Isar, Dept Nucl Med,TUM Univ Hosp, Ismaninger Str 22, D-81675 Munich, Germany

[2] Univ Lorraine, Dept Nucl Med & Nancyclotep Imaging Platform, CHRU Nancy, Nancy, France

[3] Ludwig Maximilians Univ Munchen, LMU Hosp, Dept Nucl Med, Munich, Germany

[4] Univ Hosp Padova, Dept Med, Unit Nucl Med, Padua, Italy

[5] Univ Santiago de Compostela, CIMUS, Santiago De Compostela, Spain

[6] Univ Hosp IDIS, Nucl Med Dept, Santiago De Compostela, Spain

[7] UCL, Inst Nucl Med, London, England

[8] Tech Univ Munich, TUM Univ Hosp, Sch Med, Dept Psychiat & Psychotherapy, Munich, Germany

[9] Univ Med Ctr Utrecht, Dept Radiol & Nucl Med, Utrecht, Netherlands

[10] Vienna Hlth Care Grp, Dept Diagnost & Therapeut Nucl Med, Clin Donaustadt, Vienna, Austria

[11] Aix Marseille Univ, Hop La Timone, AP HM, Inst Fresnel,CNRS,Centrale Marseille,Dept Med Nucl, Marseille, France

[12] Ghent Univ Hosp, Dept Radiol & Nucl Med, Ghent, Belgium

来源：

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2025年

关键词：

RECOMMENDATIONS; DIAGNOSIS;

D O I：

10.1007/s00259-025-07066-9

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

引用

页码：1607 / 1610

页数：4

共 24 条

[1] Highly accurate blood test for Alzheimer's disease is similar or superior to clinical cerebrospinal fluid tests
Barthelemy, Nicolas R.
Salvado, Gemma
Schindler, Suzanne E.
He, Yingxin
Janelidze, Shorena
Collij, Lyduine E.
Saef, Benjamin
Henson, Rachel L.
Chen, Charles D.
Gordon, Brian A.
Li, Yan
La Joie, Renaud
Benzinger, Tammie L. S.
Morris, John C.
Mattsson-Carlgren, Niklas
Palmqvist, Sebastian
Ossenkoppele, Rik
Rabinovici, Gil D.
Stomrud, Erik
Bateman, Randall J.
Hansson, Oskar
[J]. NATURE MEDICINE, 2024, 30 (04) : 1085 - 1095
[2] Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer's disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database
Ben Bouallegue, Faycal
Mariano-Goulart, Denis
Payoux, Pierre
[J]. ALZHEIMERS RESEARCH & THERAPY, 2017, 9
[3] Aβ status assessment in a hypothetical scenario prior to treatment with disease-modifying therapies: Evidence from 10-year real-world experience at university memory clinics
Brendel, Matthias
Parvizi, Tandis
Gnoerich, Johannes
Topfstedt, Christof Elias
Buerger, Katharina
Janowitz, Daniel
Rauchmann, Boris-Stephan
Perneczky, Robert
Kurz, Carolin
Mehrens, Dirk
Kunz, Wolfgang G.
Kusche-Palenga, Julia
Kling, Agnes Bernadette
Buchal, Antonia
Nestorova, Elizabet
Silvaieh, Sara
Wurm, Raphael
Traub-Weidinger, Tatjana
Klotz, Sigrid
Regelsberger, Guenther
Rominger, Axel
Drzezga, Alexander
Levin, Johannes
Stoegmann, Elisabeth
Franzmeier, Nicolai
Hoeglinger, Guenter U.
[J]. ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2024, 16 (04)
[4] Carrera-Muoz I., 2020, Is it Necessary Duplicate Procedures? CAR, V17, P698
[5] CDA-AMC, 2024, Health System Readiness for Disease-Modifying Therapies for Alzheimer Disease
[6] Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias
Chetelat, Gael
Arbizu, Javier
Barthel, Henryk
Garibotto, Valentina
Law, Ian
Morbelli, Silvia
van de Giessen, Elsmarieke
Agosta, Federica
Barkhof, Frederik
Brooks, David J.
Carrillo, Maria C.
Dubois, Bruno
Fjell, Anders M.
Frisoni, Giovanni B.
Hansson, Oskar
Herholz, Karl
Hutton, Brian F.
Jack, Clifford R., Jr.
Lammertsma, Adriaan A.
Landau, Susan M.
Minoshima, Satoshi
Nobili, Flavio
Nordberg, Agneta
Ossenkoppele, Rik
Oyen, Wim J. G.
Perani, Daniela
Rabinovici, Gil D.
Scheltens, Philip
Villemagne, Victor L.
Zetterberg, Henrik
Drzezga, Alexander
[J]. LANCET NEUROLOGY, 2020, 19 (11) : 951 - 962
[7] Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group
Dubois, Bruno
Villain, Nicolas
Frisoni, Giovanni B.
Rabinovici, Gil D.
Sabbagh, Marwan
Cappa, Stefano
Bejanin, Alexandre
Bombois, Stephanie
Epelbaum, Stephane
Teichmann, Marc
Habert, Marie-Odile
Nordberg, Agneta
Blennow, Kaj
Galasko, Douglas
Stern, Yaakov
Rowe, Christopher C.
Salloway, Stephen
Schneider, Lon S.
Cummings, Jeffrey L.
Feldman, Howard H.
[J]. LANCET NEUROLOGY, 2021, 20 (06) : 484 - 496
[8] European Academy of Neurology, 2024, welcomes EMA approval of lecanemab for Alzheimer's disease treatment. eanpages
[9] European Medicines Agency, 2024, Leqembi
[10] Amyloid-Related Imaging Abnormalities and β-Amyloid-Targeting Antibodies A Systematic Review
Filippi, Massimo
Cecchetti, Giordano
Spinelli, Edoardo Gioele
Vezzulli, Paolo
Falini, Andrea
Agosta, Federica
[J]. JAMA NEUROLOGY, 2022, 79 (03) : 291 - 304

← 1 2 3 →